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Prevalence of herbal and dietary supplement
usage in Thai outpatients with chronic kidney
disease: a cross-sectional survey
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Abstract
Background: There are few studies of the prevalence and patterns of herbal and dietary supplement (HDS) use in
patients with chronic kidney disease (CKD), although many researchers and health professionals worldwide have
raised concern about the potential effects of HDS on patients with renal insufficiency. A survey was conducted to
determine: the prevalence and patterns of HDS use in Thai patients with CKD; the demographic factors related to
HDS use; the reasons why Thai patients with CKD use HDS; respondent experiences of benefits and adverse effects
from HDS; and the association between conventional medication adherence and HDS use.
Methods: This cross-sectional survey recruited patients with CKD attending two teaching hospitals in Thailand. Data
were collected via an interview using a semi-structured interview schedule regarding demographics, HDS usage,
reasons for HDS use, and respondent experiences of effects from HDS. Conventional medication adherence was
measured using the Thai version of 8-Item Morisky Medication Adherence Scale. Descriptive statistics were used to
analyse the prevalence and the patterns of HDS use. Chi-square tests and multiple logistic regression were used to
determine any associations between HDS use, demographics and conventional medication adherence.
Results: Four hundred and twenty-one eligible patients were recruited. The prevalence of HDS use in the previous
12 months was 45%. There were no demographic differences between HDS users and non-users, except former
drinkers were less likely to use HDS, compared with non-drinkers (OR 0.43, 95% CI 0.25-0.75). Those with a medium
level of adherence to conventional medication were less likely to use HDS compared with those with a low level of
adherence (OR 0.53, 95% CI 0.32-0.87). Maintaining well-being was most common purpose for using HDS (36%).
Nearly 18% used HDS, such as holy mushroom, river spiderwort and boesenbergia, to treat kidney disease. The top
three most often reported reasons why respondents used HDS were family and friend’s recommendation, followed
by expecting to gain benefit from HDS and wanting to try them. Perceived beneficial effects on renal function from
HDS were reported by around 10% of HDS users. Among HDS users, seven patients perceived worsening CKD from
HDS, such as river spiderwort, kariyat and wheatgrass. Additionally, 72% of respondents did not inform their doctor
about their HDS use mainly because their doctor did not ask (46%) or would disapprove of their HDS use (15%).
Conclusions: Around half of the Thai patients with CKD used HDS. Health professionals should be aware of HDS
use amongst such patients and enquire about HDS use as a part of standard practice in order to prevent any
detrimental effects on kidney function.
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Background
There is widespread use of herbal and dietary supple-
ment (HDS), particularly in Asian countries [1]. The
prevalence of HDS use in the general population ranges
from 22% to 77% across Asian countries [2-7]. Patients
with chronic diseases, such as diabetes, cardiovascular
diseases and cancer have been reported as being more
likely to use HDS [8] and the prevalence of HDS use in
these populations ranges from 32% to 77% in Thailand,
the US and Malaysia [9-13]. There are no differences in
the demographic characteristics between HDS users and
non-users in patients with chronic illnesses, including
CKD regarding age, gender, education and smoking sta-
tus [9,11,14]. This differs from HDS users in the general
populations, who are more likely to be elderly, female,
and educated to a higher level in both Asian and western
countries [5,15,16]. Whilst patients in Asian countries
reported family and friend’s recommendations [9,13,17]
as the main reason for using either complementary and
alternative medicine (CAM) or herbal medicine, amongst
patients with chronic diseases in the US they are used to
supplement conventional medicines and because patients
want to try HDS [18]. Spanner and Duncan state that pre-
vention is the main reason for using HDS amongst pa-
tients with CKD [14]. Although populations with long
term conditions have a higher prevalence of HDS use,
more than half of patients with chronic illnesses reported
not informing either their doctor or health care providers
about their HDS use [9,12,13,17,18]. In contrast, patients
with CKD were more likely to inform their health care
providers about their HDS use (55-67%) [14,19].
The use of CAM, including HDS use has been shown to
be related to poor adherence to conventional medication
[20,21]. However, Cherniack (2011) found no association
between CAM use and medication adherence [22]. There
are limited and controversial suggestions as to whether
HDS use negatively influences conventional medication
adherence [20-23] due to depressive symptoms, costs
of conventional medications and dis-satisfaction with
the doctor-patient relationship in patients with hyper-
tension [20].
Chronic kidney disease (CKD) is a worldwide health
problem leading to a decreased quality of life and increased
mortality, and is a condition where the kidneys no longer
function as they should due to a decrease in kidney mass,
development of glomerular hypertension and intratubular
proteinuria. It is classified on a scale of 1–5 based on a level
of glomerular filtration rate, with 5 being the lowest level of
function. There is a high prevalence of stage 3–5 CKD in
the Thai population (8.9%) [24], compared to the median
worldwide prevalence of CKD (7.2%) [25]. Stage 3–5 CKD,
an estimated glomerular filtration rate (eGFR) of less than
60 ml/min, is associated with a high number of complica-
tions [26] so these patients may be more vulnerable to any
HDS adverse effects. Additionally, it has been documented
in many recent studies that several HDS induce adverse
renal effects ranging from worsening kidney function to
renal failure, these include aristolochic acid, fangchi and L-
glutamine [2,4,27-30]. This has led to concerns about detri-
mental effects of HDS use in patients with CKD. Despite
the concerns of practitioners, only a few surveys in western
countries have investigated HDS use in patients with CKD
[14,19]. Grabe and Garrison (2004) in the US found 29% of
patients with CKD used HDS, whilst Spanner and Duncan
(2005) in Canada reported 45% used HDS. However, these
studies had small populations and did not investigate
patient’s experiences of positive and negative effects of
HDS on kidney function or the association between HDS
use and adherence to conventional medication. Given the
concerns about the effect of HDS on renal function and
the higher prevalence of HDS use in Asian countries, it
is important to establish the extent and patterns of use
amongst CKD patients in Asian countries so health care
providers can be better informed and advise their patients
accordingly.
To promote herb product use amongst Thai residents
and to provide appropriate dosage regimens and indica-
tions for such products, the Thai Food and Drug Ad-
ministration has issued guidance for their safe and
effective use [31]. Seventy-one items of Thai folk herbal
products, both herbal combinations and single herbal
medicines, are in the Thai National List of Essential
Medicines (2011). Senna, roselle, java tea and folk rem-
edies, such as ‘Ya Hom’ and ‘Ka sai’ are listed in the Thai
National List for alleviating common illnesses but are
not recommended for patients with renal insufficiency
by the Thai Food and Drug Administration. High dose
senna can induce nephritis, whilst roselle and java tea
can affect electrolyte imbalance in patients with CKD.
Ya Hom and Ka Sai contain camphor, which can accu-
mulate in the body and thus result in renal toxicity [31].
The aims of this survey were to determine: the preva-
lence and patterns of HDS use in Thai patients with
CKD; demographic factors related to HDS use, including
the association between conventional medication adher-
ence and HDS use; reasons why Thai CKD patients use
HDS; and respondent experiences of benefit and adverse
effects from HDS.
Methods
A cross-sectional survey was conducted from January to
June 2012 in kidney clinics in two teaching hospitals, King
Chulalongkorn Memorial Hospital in Bangkok represent-
ing an urban population and HRH Princess Maha Chakri
Sirindhorn Medical Center in Nakhon-Nayok province
representing a rural population. Both hospitals are in the
central part of Thailand, which has the second highest
prevalence of CKD in the country [4]. The study was
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approved by the Institutional Review Board for Research in
Human Subjects at Faculty of Medicine, Chulalongkorn
University and Srinakharinwirot University, Thailand, and
the Medical School Research Ethics Committee of the Uni-
versity of Nottingham, UK.
A nineteen-item semi-structured questionnaire was
adapted from previously developed surveys on herbal
medicine designed by Kuo et al. [32] with added ques-
tions in order to achieve the research outcomes. This
questionnaire was piloted to test the understanding of
the questions and the validity and test-retest reliability
(intraclass correlation coefficient = 0.73) in a CKD popu-
lation of the Thai version of 8-Item Morisky Medication
Adherence Scale (MMAS-8) [33]. With respect to valid-
ity, low medication adherence measured by MMAS-8
had a trend towards worsening CKD; however the total
number of respondents was not sufficient to estimate
the relationship with a standard error of 5%. The final
version of questionnaire consisted of four parts, demo-
graphic characteristics, HDS use, experiences of benefits
and adverse effects from HDS, and the Thai version of
MMAS-8, see Additional file 1. Demographic character-
istics included age, gender, current address, education,
occupation, smoking status and alcohol consumption.
Household income was not included as in the pilot study
half of the respondents were unwilling to provide this
information. HDS usage included types, medical pur-
poses, dosage forms, doses and duration of HDS use,
reasons why respondents use HDS, information sources,
how they obtained the HDS and the disclosure of HDS
use to their doctor.
The prevalence of HDS usage was defined as regular
or occasional use during the previous 12 months. HDS
were defined as products containing plant-derived ma-
terial, either raw or processed ingredients, from one or
more plants or containing dietary ingredients, such as
vitamins, minerals, amino acids and substances, such as,
enzymes, organ tissues, glands and metabolites [34,35].
Additionally, this study focused on HDS use for the
treatment of illnesses or health promotion rather than
consumption for daily food intake or cosmetic purposes
and did not include prescribed dietary supplements.
Inclusion criteria were: adult outpatients with CKD di-
agnosed by a doctor; an eGFR level of less than 60 ml/
min calculated by the Thai Modification of Diet in Renal
Disease equation [36]; and that the patients attended a
kidney clinic at either setting. Patients who had received
either dialysis or a kidney transplant were excluded. All
patients who met the inclusion criteria were approached
by MT and other trained interviewers in order to deter-
mine their willingness to participate in this survey. If
they consented, a 19-item semi-structured questionnaire
with samples of HDS pictures was administered in face-
to-face interviews.
Data analysis consisted of simple frequencies with per-
centages which were used to determine the prevalence
of HDS use and descriptive results. Chi-square tests were
performed to determine the factors related to HDS use
and any associations between HDS use and conventional
medication adherence. Multiple logistic regression ana-
lyses were undertaken to determine associations between
HDS use and demographic characteristics and conven-
tional medication adherence. Tests were 2-tailed, and a p-
value < 0.05 was considered statistically significant.
Results
Demographic characteristics of respondents
The total number of respondents was 444 of which 23
(5%) were excluded. Receiving dialysis (n=15) was the main
reason for exclusion. Four patients (1%) did not give their
consent and another four patients were unable to provide
information due to illnesses. Respondents had a mean age
of 66 years (SD ± 13) and 54% were women. The majority
of respondents were retired (68%) and had stage 3 CKD
(71%). Comparing demographics between the population
in this survey and the Thai general population found that
there were no differences regarding gender, education
levels, living in urban or rural areas, smoking and drinking
status [37]. However, respondents in the present survey
were older than the general CKD population (mean ± SD:
56.8 ± 14.5) [24].
The prevalence of HDS use amongst patients with CKD
was 45%. Almost all HDS users combined them with their
prescribed, conventional medicines (99%). Demographic
characteristics of HDS users and non-users are shown in
Table 1. Comparisons between HDS users and non-users
found that conventional medication adherence differed
across the groups with HDS users more likely to have
poor medication adherence (χ2 = 8.46, p = 0.015), other
comparisons found no differences between the groups.
Further analysis using multiple logistic regression found
that former drinkers (Odds ratio (OR) 0.43, 95% CI 0.25-
0.75) and respondents having a medium level of adher-
ence to prescribed, conventional medicines (OR 0.53, 95%
CI 0.32-0.87) were less likely to use HDS than non-
drinkers and those reporting poor adherence. No other
statistically significant factors associated with HDS use
were found, see Table 2.
Herbal and dietary supplement use
Of the respondents using HDS (n=189), a total of 64%
reported using herbal medicines and 36% used dietary
supplements, with 14% using both. The mean number of
different HDS used was 1.6 (SD ± 0.9) products. Oral
capsules or tablets were the usual forms of HDS used
(51%) of which 11% were traditional Thai or Chinese
pills called ‘Luke Klon’, which is a black round pill. Seven
percent of the products used were non-processed herbs.
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Nearly three quarters of the products were used daily
(71%) and half of products had been used for less than a
year (52%).
Purposes of using HDS were for maintaining well-
being (36%), followed by the treatment of other chronic
diseases (24%), minor ailments (19%), and kidney dis-
eases (17%). Herbs tended to be used for illnesses,
including other chronic diseases, kidney diseases, minor
ailments and leg oedema (80%); whereas most dietary
supplements were used for well-being (69%).
Family and friends were an important influencing factor
for respondents choosing to use HDS (35%). They pro-
vided not only HDS information (52%), but also the HDS
products (27%), see Table 3. The next most frequently
cited reasons for HDS use were that respondents per-
ceived that they would gain benefits from the HDS (22%)
and were willing to try HDS (19%). Television, radio and
internet (23%) were reported as the second sources of
HDS information, followed by health care providers (5%).
Table 1 Comparison of characteristics between HDS users
and non-users (n=421)
Characteristics HDS user
(n=189)
Non user
(n=232)
χ
2
p-value
Age 0.334
≤ 60 62 (32.8%) 66 (28.4%)
> 60 127 (67.2%) 166 (71.6%)
Gender 0.708
Male 89 (47.1%) 105 (45.3%)
Female 100 (52.9%) 127 (54.7%)
Education 0.862
Less than secondary
school
104 (55.3%) 130 (56.0%)
Secondary school 27 (14.4%) 40 (17.2%)
Vocational degree 14 (7.4%) 15 (6.5%)
Undergraduate
degree
34 (18.1%) 35 (15.1%)
Higher than
undergraduate degree
9 (4.8%) 12 (5.2%)
Address 0.186
Capital city 60 (31.7%) 88 (37.9%)
Rural areas 129 (68.3%) 144 (62.1%)
Smoking status 0.812
Never 122 (64.6%) 147 (63.4%)
Former 59 (31.2%) 72 (31.0%)
Current 8 (4.2%) 13 (5.6%)
Alcoholic consumption 0.080
Never 119 (63.3%) 121 (52.4%)
Former 60 (31.9%) 96 (41.5%)
Current 9 (4.8%) 14 (6.1%)
Stages of CKD 0.936
3 133 (70.4%) 164 (70.7%)
4 49 (25.9%) 58 (25.0%)
5 7 (3.7%) 10 (4.3%)
Medication adherence** 0.015*
Low 61 (32.3%) 47 (20.2%)
Medium 79 (41.8%) 122 (52.6%)
High 49 (25.9%) 63 (27.2%)
* Statistically significant at p < 0.05; ** Medication adherence was measured
using the Thai version of 8-Item Morisky Medication Adherence Scale; Low,
medium and high adherence was defined as MMAS < 6, 6 < MMAS < 8,
MMAS = 8, respectively.
Table 2 Multiple logistic regression analysis of factors
related to HDS use in patients with CKD (n=421)
Factors Odds ratio 95% Confidence
interval
Age
≤ 60 1.00
> 60 0.84 0.52-1.36
Gender
Male 1.00
Female 0.77 0.47-1.29
Education
Less than secondary school 1.00
Secondary school 0.77 0.43-1.40
Vocational degree 1.11 0.48-2.52
Undergraduate degree 1.16 0.64-2.11
Higher than undergraduate degree 0.88 0.33-2.36
Current address
Capital city 1.00
Rural address 1.38 0.90-2.12
Smoking status
Never smoked 1.00
Former smoker 1.57 0.85-2.89
Current smoker 0.90 0.33-2.47
Alcohol consumption
Never 1.00
Former drinker 0.43 0.25-0.75
Current drinker 0.52 0.20-1.33
Stages of CKD
3 1.00
4 1.02 0.64-1.64
5 0.92 0.32-2.63
Prescribed, conventional medication adherence
Low 1.00
Medium 0.53 0.32-0.87
High 0.68 0.39-1.20
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Most HDS products were bought from pharmacies,
herbal or dietary supplement shops (41%), followed by
direct sale HDS companies (30%) who advertise on satel-
lite television or radio to sell their products. Collecting
herbs from their own garden were reported by 9% of re-
spondents. Importantly, most respondents reported that
they did not inform their doctor about HDS use (72%)
and the main reason for this was that their doctor did
not ask them (46%), see Table 4.
Types of HDS use and perception of benefits and adverse
effects from HDS
Amongst 304 different HDS used, there were 58 differ-
ent herbal products and 18 different dietary supplement
products used. Of the herbal products, 66% were a single
herbal use and 34% were a herbal combination. However,
51 HDS products (17%) were unknown as respondents did
not either know or remember their ingredients. Kariyat
(12%), turmeric (10%) and horseradish tree (8%) were the
three were most used herbs, see Table 5. Senna, folk
remedies “Ya Hom” and “Ka Sai”, java tea and roselle juice
were also reported (6%).
Vitamins and minerals were the most often reported
dietary supplements used (16%, n=17) of which vitamin
C (n=6) and calcium supplements (n=4) were most com-
mon (Table 6), followed by essence of chicken drink
(13%) and germ oil (12%).
Regarding perception of benefits from HDS, around three
quarters of the HDS used were reported to have benefits
(74%). The reported benefits were alleviation of minor ail-
ments, such as constipation (24%), musculoskeletal pain
(19%) and flatulence (15%), followed by enhanced well-
being (28%) and slowing the progression of their CKD (9%)
meaning a decrease in serum creatinine. There were nine
different HDS which respondents reported slowing the pro-
gression of their CKD: Holy mushrooms (n=3), a herbal
combination – Boesenbergia, mint, ginger, galangal, lemon-
grass, kaffir lime leaves and shallots (n=1), a herbal com-
bination - Boesenbergia, onion, galangal, lemongrass, kaffir
lime leaves, lime leaves and mint (n=1), turmeric (n=1),
Spring bitter cucumber (n=1), a Chinese folk remedy -
Cordyceps, Angelica sinensis, Chinese Wolfberry, Astrag-
alus (Astragalus membranaceus), Eucommia ulmoides,
Codonopsis pilosula and deer antler velvet (n=1), a herbal
combination - Jujube, roselle, boesenbergia and mixed 3
types of mushrooms (n=1), spirulina (n=1) and mangosteen
peel juice (n=1).
In contrast, only 10% reported adverse effects from
HDS use of which the progression of CKD defined as an
increase in serum creatinine or having proteinuria was the
Table 3 Reasons for HDS use and information
sources (n=189)
Frequency Percentage
Reasons (n=317)*
Family/friend’s recommendation 111 35.0
HDS will work 71 22.4
Willing to try anything that helps 61 19.2
Prefer to use HDS 34 10.7
Health care provider’s recommendation 21 6.6
Safer than conventional medicines 9 2.8
Easy access 5 1.6
Recommended by traditional practitioners
or HDS sellers
2 0.7
Experienced adverse effects from
conventional medicines
2 0.7
Recommended by other patients with CKD 1 0.3
Information sources (n=222)*
Family and friends 115 51.8
TV, radio or internet 50 22.5
Health care providers 12 5.4
Books or newspapers 12 5.4
Traditional practitioners 8 3.6
HDS companies 7 3.1
Leaflets from HDS companies 7 3.1
Own knowledge of HDS 7 3.1
Other patients with CKD 2 1.0
Scientific evidence 2 1.0
* Respondents reported more than one reason and more than one
information source, so these total more than 189.
Table 4 Disclosure of HDS use to doctors and the reasons
for not disclosing (n=189)
Frequency Percentage
Informed their doctor about their HDS use
Yes 53 28.0
No 136 72.0
Reasons for not reporting HDS use (n=144)*
Health care providers don’t ask 66 45.8
Patients worried that their doctor will
disapprove of HDS use
22 15.3
Short-term or occasional use 19 13.2
No need to inform their practitioner 18 12.5
Didn’t see their doctor during the
period of HDS use
8 5.5
Just start using HDS and no opportunity 4 2.8
Stopping or planning to stop using HDS 3 2.1
Don’t want to tell them 2 1.4
HDS are safe 1 0.7
Doesn’t influence their disease (s) 1 0.7
* Respondents reported more than one reason, so these total more than 136.
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most often reported adverse effect (37%), followed by gas-
trointestinal symptoms (16%) and neurological symptoms
(16%). Three products with reported increased serum
creatinine were products where the respondents did not
know the ingredients.
Discussion
The population in the current survey (mean ± SD: 66 ± 13)
was older than Thai general CKD population (mean ± SD:
56.8 ± 14.5) [24]. However, there was no significant dif-
ference comparing with literature on the prevalence of
Table 5 Herbs used; respondents reported purposes and adverse effects (n=199)*
Types of herb used Frequency (%) Main purpose given
by respondents
Adverse effects
experienced
Kariyat (Andrographis paniculata) 23 (11.6) Common cold, fever,
sore throat, diabetes
Increased SCr
Turmeric (Curcuma longa) 19 (9.5) Gastrointestinal symptoms**,
constipation, CKD
-
Horseradish tree (Moringa oleifera) 16 (8.0) Diabetes, hypertension, constipation Unable to stop bleeding
Mixed botanical extract or fruit drink 12 (6.0) CKD, diabetes, well-being -
Ginseng (Panax spp.) 7 (3.5) Well-being -
Holy mushroom (Garnoderma lucidum) 5 (2.5) CKD Oedema
River spiderwort (Tradescantia fluminensis) 4 (2.0) CKD Increased SCr, fatigue
Babbler’s Bill Leaf (Thunbergia laurifolia) 3 (1.5) Detoxification, diabetes -
Senna (Senna alexandrina) 3 (1.5) Constipation -
Ginkgo (Ginkgo biloba) 3 (1.5) Improved brain function -
Boesenbergia (Boesenbergia rotunda) 3 (1.5) CKD -
Garlic 3 (1.5) Dyslipidemia -
Mixed Thai traditional herbs called “Ya Hom” 3 (1.5) Well-being, fainting, dizziness -
Heart-leaved moonseed (Tinospora cripa) 3 (1.5) Diabetes,well-being -
Coix seed (Semen Coicis) 3 (1.5) CKD, well-being, diabetes -
Vap Ca (Houttuynia cordata) 2 (1.0) Kidney stones, CKD -
Aloe (Aloe vera) 2 (1.0) Diuretic effects, well-being -
Blue Pea (Clitoria ternatea) 2 (1.0) CKD -
Mixed 3 or 6 types of mushrooms 2 (1.0) CKD -
Shiitake mushroom (Lentinus edodes) 2 (1.0) CKD, well-being -
Cinnamon (Cinnamomum verum) 2 (1.0) Diabetes -
Mixed Thai traditional herbs called “Ya Khom” 2 (1.0) Fever -
Mixed Thai traditional herbs called “Ka Sai” 2 (1.0) Constipation, well-being -
Jujube (Zizyphus mauritiana) and Roselle (Hibiscus sabdariffa) 2 (1.0) CKD, dyslipidemia -
Spirulina 2 (1.0) Detoxification, diabetes -
Lemongrass 1 (0.5) Dyslipidemia and CKD -
Boesenbergia, sweet basil, honey and lime juice 1 (0.5) CKD Fainting
Boesenbergia, mint, ginger, galangal, lemongrass,
kaffir lime leaves and shallots
1 (0.5) CKD -
Spring bitter cucumber (Momordica cochinchinensis) 1 (0.5) CKD -
Lime 1 (0.5) Kidney stones -
Chinese folk remedy - Cordyceps, Lovage (Angelica sinensis), deer
antler velvet, cinnamon and Schisandra berry (Schisandra chinensis)
1 (0.5) CKD -
Paragrass roots (Brachiaria mutica) and pomegranate leaves
(Punica granatum)
1 (0.5) CKD -
Leaves of Clerodendrum petasites 1 (0.5) CKD -
Java tea 1 (0.5) Diuretic effects -
* Respondents reported more than one type of herb used.
** Flatulance, dyspepsia and peptic ulcers; SCr = Serum creatinine.
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HDS use amongst patients with CKD in Canada (HDS
users 64.1±11.6; non-users 60.4±15.0) [14].
The prevalence of HDS use amongst Thai CKD patients
was 45%. There were no differences in demographic char-
acteristics between HDS users and non-users in relation
to age, gender, smoking status or education. Although this
prevalence cannot be directly compared with previous
surveys of HDS use in Thailand due to the different defi-
nition of HDS use, this prevalence is similar to a survey
of HDS use in Thai patients with chronic diseases (45%)
[10]. We found the prevalence of HDS use in patients with
CKD was greater than the prevalence of herbal use in Thai
general population (33%) [4]. The prevalence of the
current study is consistent with Spanner and Duncan’s
survey (2005) in Canada [14], although their study was
using a different population, and they used slightly differ-
ent definitions of HDS use - defined as current daily in-
take by Spanner and Duncan.
The current study found a significant association be-
tween HDS use and poor adherence to conventional
medication. However, there was no relationship between
HDS use and a high level of adherence to conventional
medication. Reasons for these associations are unknown.
Likewise, Krousel-Wood et al. (2010) in the US and
Gohar et al. (2008) in the UK found a significant associ-
ation between the use of CAM and a low level of adher-
ence to conventional medicines amongst patients with
hypertension, the association was stronger in African-
Americans and women [20,21]. There is no clear pattern
of this association and the reason for the association has
not been investigated, so further studies are needed be-
fore firm conclusions can be made.
Non-drinkers were more likely to use HDS than former
drinkers in the current survey. However, there is no litera-
ture describing the association between HDS use and
drinking in patients with chronic diseases. Our results
contrast with US national surveys of CAM users amongst
young adults in 2000 where they found former drinkers
were more likely to use CAM [38]. This difference could
be due to the differing populations especially in relation to
age. Further studies are required to examine this associ-
ation in patients with other chronic diseases.
Treatment of chronic kidney diseases was not the main
purpose in using HDS. Almost all patients combined HDS
with conventional medicines rather using it as a substitute.
There is some consistency with surveys of either CAM or
herbal use amongst patients with chronic illnesses in
Asian and western countries [9,12,17,18]. All HDS prod-
ucts reported as being used for CKD, except Astragalus
membranaceus, have no scientific evidence to demon-
strate their efficacy from clinical trials. Proteinuria, which
indicates worsening kidney function, was reported as an
adverse effect of using protein supplements - high protein
intake is related to a decrease in renal function [39]. River
spiderwort, kariyat and wheatgrass were reported by re-
spondents to increase serum creatinine. However, there is
no evidence in the literature to support this and therefore
research is needed to determine whether or not such HDS
would be harmful or beneficial to patients with CKD.
The Thai National List of Essential Medicines (2011)
states that for patients with CKD senna, java tea, roselle,
Ya Hom and Ka sai are not recommended [31]. How-
ever, we found that some respondents used these prod-
ucts (6%). Given the low number of respondents who
reported their HDS use to their doctor, health care pro-
viders need to ask patients about such HDS use and ex-
plain why it could worsen their condition.
Family and friends influence patient’s decision-making re-
garding HDS use amongst Asian populations as supported
by this study and other studies of either CAM or herbal use
in patients with chronic illnesses in Thailand and Malaysia
[9,12,13,17]. Wanting to try HDS was an often reported
Table 6 Dietary supplements used; respondents reported purposes and adverse effects (n=105)*
Types of dietary supplement used Frequency (%) Purposes given by respondents Adverse effects experienced
Vitamins and minerals 17 (16.2) Well-being Weight gain
Essence of chicken drink 14 (13.3) Well-being Increased blood sugar
Germ oil 13 (12.4) Well-being -
Rice Bran oil 9 (8.6) Well-being, CKD, diabetes -
Fish oil 8 (7.6) Well-being, cardiovascular diseases -
Protein 7 (6.7) Well-being Proteinuria
Chlorophyll 6 (5.7) Well-being, CKD, diabetes, hypertension -
Swiftlet’s nest drink 5 (4.8) Well-being -
Bee pollen 2 (1.9) Well-being -
Wheatgrass 2 (1.9) Well-being Increased SCr
Fibre 2 (1.9) Constipation -
Coconut oil 1 (0.9) Well-being Diarrhoea
* Respondents reported more than one type of dietary supplement used; SCr = Serum creatinine.
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reason for using HDS, which was also been reported in
other surveys of CAM use amongst patients with chronic
illnesses in both Asian and western countries [12,18].
Several surveys in Thailand, Malaysia and the US have
reported that most patients with chronic diseases, other
than CKD, did not disclose their HDS use to their con-
ventional health care providers [9,12,17,18,40]. In con-
trast, patients with CKD in Canada and the US were
more likely to inform their doctor about their HDS use
(67% and 55%, respectively) than patients with other
chronic diseases (33%) [14,19]. However, this contrasts
with the current study and should be highlighted that
most patients in this study did not inform their doctor
about their HDS use (72%). It would seem that an Asian
population is less likely to disclose their HDS use to
their conventional health professionals, compared with
western populations [40]. Most often reported reasons
of non-disclosure were that their doctor did not enquire,
they may disapprove of their HDS use or they did not
need to know about their HDS use, which is consistent
with Robinson and McGrail’s systematic review [41].
The findings suggest that conventional health care pro-
viders should be aware of the prevalence of HDS use in pa-
tients with CKD. They should always ask about their
patient’s use of HDS, monitor the impact of HDS on CKD,
and be prepared to discuss information about how to safely
use HDS products with the patient and their caregivers.
Conclusions
Around half of Thai patients with CKD used HDS; how-
ever most of them did not disclose this use to their con-
ventional health care providers. HDS use was significantly
associated with a low level of adherence to conventional
medicine. Some products were reported to be used to treat
their CKD and were perceived to have beneficial effects on
kidney function – despite any robust clinical evidence of
efficacy. Moreover, some patients perceived renal adverse
effects from HDS, which have never been reported in the
literature. These findings should be addressed by conven-
tional health care providers in order to prevent detrimen-
tal effects of HDS on patients with CKD. Health care
providers should enquire about HDS use in patients with
CKD as a part of standard practice. Sellers of HDS should
ensure appropriate information about their products safety
is available to purchasers. Further studies are required to
investigate the efficacy and safety of HDS used by patients
with CKD.
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